The Journal of Medical Sciences

Register      Login

VOLUME 3 , ISSUE 2 ( April-June, 2017 ) > List of Articles

ORIGINAL ARTICLE

Role of High-sensitivity C-reactive Protein as a Predictor of Severity of Chronic Obstructive Pulmonary Disease in Correlation with Clinical Parameters

Mamatha B Patil, M Abhishek, BK Pradeep

Citation Information :

DOI: 10.5005/jp-journals-10045-0056

License: CC BY 3.0

Published Online: 00-06-2017

Copyright Statement:  Copyright © 2017; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Introduction

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality throughout the world. By 2020, the World Health Organization predicts that COPD will become the third leading cause of death and the fifth leading cause of disability worldwide. The COPD is a complex disease characterized by slowly progressive and largely irreversible airflow obstruction due to chronic bronchitis and emphysema and associated with systemic inflammation.

Objective

This study aimed to correlate the plasma levels of high-sensitivity C-reactive protein (hs-CRP) with severity of COPD and pulmonary function tests [PFTs; according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages] and find out the relation between hs-CRP levels and clinical parameters of age, number of pack years, and body mass index (BMI) of the patient.

Materials and methods

A cross-sectional study of 102 male patients with clinically and spirometrically diagnosed cases of COPD was performed. Data on patient's demographic characteristics, pack years, BMI, PFTs, and hs-CRP were analyzed.

Results

A total of 76 of the patients had moderate airflow obstruction (GOLD stages II and III), mild airflow obstruction was present in 14 patients (GOLD stage I), and 12 patients had severe airflow obstruction (GOLD stage IV). The hs-CRP was normal in 6 patients, while it was raised in 96 patients. The value of hs-CRP was correlated with age, pack years, BMI, and GOLD stages. There was a significant negative correlation between hs-CRP and BMI and a significant positive correlation between hs-CRP and age, pack years, and GOLD stages.

Conclusion

A raised level of CRP in COPD indicates reduced lung function; it plays an important role in systemic inflammation. This study supports the role of hs-CRP as a simple, cost-effective biochemical marker in the staging and determining the severity of COPD other than spirometry.

How to cite this article

Patil MB, Abhishek M, Pradeep BK. Role of High-sensitivity C-reactive Protein as a Predictor of Severity of Chronic Obstructive Pulmonary Disease in Correlation with Clinical Parameters. J Med Sci 2017;3(2):50-54.


PDF Share
  1. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001;163:1256-127.
  2. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-1504.
  3. org 2014 update: executive summary, global strategy for diagnosis, management and prevention of COPD; January 2014.
  4. The physiological structure of human C- reactive protein and its complex with phosphocholine. Structure 1999; 7 (2):169-177.
  5. C-reactive protein: a critical update. J Clin Invest 2003; 111(12):1805-1812.
  6. C reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250-255. [17053205]
  7. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003;107:1514-1519.
  8. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996;51:819-824.
  9. Elevated TNF-α production by peripheral blood monocytes of weightlosing COPD patients. Am J Respir Crit Care Med 1996;153:633-637.
  10. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006;27:902-907.
  11. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59:574-580.
  12. The added value of C-reactive protein to clinical signs and symptoms in patients with obstructive airway disease: results of a diagnostic study in primary care. BMC Fam Pract 2006;7:28.
  13. C-reactive protein fifty years on. Lancet 1981;1:653-657.
  14. Association of High Sensitive CRP Level and COPD Assessment Test Scores with Clinically Important Predictive Outcomes in Stable COPD Patients. Tanaffos 2015; 14(1):34-41.
  15. The 6-min walking distance: long-term follow up in patients with COPD. Eur Respir J 2007; 29:535-540.
  16. Iran Red Crescent Med J 2011; 13(10):713-718.
  17. Survey Of Prevalence Of Chronic Bronchitis In Madras City. In: Viswanathan R, Jaggi OP, editors. Advances in chronic obstructive lung disease. Delhi; Asthma and Bronchitis Foundation of India 1977; 59-69.
  18. Behaviour on follow-up in chronic obstructive pulmonary disease. Lung India; 1984 Feb; 2(1): 76-83.
  19. Ashok K Factors associated with hospital admission in patients with acute exacerbation of COPD. CHEST 2011; 52:203-206.
  20. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006; 27: 902-907.
  21. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:250-255.
  22. Iran Red Crescent Med J 2011; 13(10):713-718.
  23. Highly sensitive Creactive protein levels in Iranian patients with pulmonarycomplications of sulfur mustard poisoning & its correlation with severity of airway diseases. Hum Exp Toxicol 2009;28:739-745.
  24. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006; 27:902-907.
  25. Highly elevated C-reactive protein levels in obese patients with COPD: A fat chance? Clin Nutr 2009;28:642-647.
  26. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 2006; 27:902-907.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.